Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Guideline

KASL Guidelines : Management of Chronic Hepatitis B

Kwan Sik Lee, M.D.1, Dong Joon Kim, M.D.2, Guideline Committee of the Korean Association for the Study of the Liver
Clin Mol Hepatol 2007;13(4):447-488. Published online: December 20, 2007
Chairman of Scientific Committee1, Scientific Secretary2 of the Korean Association for the Study of the Liver
  • 8,151 Views
  • 41 Download
  • 44 Crossref
  • 34 Scopus
next

Citations

Citations to this article as recorded by  Crossref logo
  • Macro-Aspartate Aminotransferase Elevation in a Patient with Chronic Hepatitis B
    Nae-Yun Heo, Jae-Hoon Kim, Seungha Park, Joon Hyuk Choi, Tae Oh Kim, Jin Lee, Yong Eun Park, Kyung Ran Jun
    The Korean Journal of Gastroenterology.2026; 86(2): 122.     CrossRef
  • ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
    Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Won Young Tak, Young-Oh Kweon, Soo Young Park, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2023; 21(9): 2278.     CrossRef
  • Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B
    Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Won Young Tak, Jun Yong Park, Young-Oh Kweon, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Soo Young Park, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2022; 20(4): e794.     CrossRef
  • Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
    Mi Na Kim, Seong Gyu Hwang, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seung Up Kim, Sang Hoon Ahn
    Gut and Liver.2019; 13(2): 197.     CrossRef
  • Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
    Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
    Gut and Liver.2017; 11(1): 129.     CrossRef
  • KASL clinical practice guidelines: management of chronic hepatitis B

    Clinical and Molecular Hepatology.2016; 22(1): 18.     CrossRef
  • Hepatitis B Virus Infection in B-Cell Non-Hodgkin’s Lymphoma, and Effect of Entecavir in Prophylactic Antiviral Therapy
    Jinjing Chen, Haizhen Yi, Hong Cen, Wei Yan
    Health.2016; 08(05): 495.     CrossRef
  • Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
    Seungtaek Lim, Jungwoo Han, Gun Min Kim, Kwang‐Hyub Han, Hye Jin Choi
    Journal of Gastroenterology and Hepatology.2015; 30(6): 1024.     CrossRef
  • Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review
    Hye Jin Jeong, Ji Min Lee, Tae Han Lee, Ji Yeon Lee, Han Byeol Kim, Mi Hwa Heo, Go Choi, Jin Nyeong Chae, Ji-Min Kim, Sang-Hyon Kim, Kun Young Kwon
    Journal of Bone Metabolism.2014; 21(1): 76.     CrossRef
  • Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy
    Hyun Jung Lee, Dae Young Kim, Bhumsuk Keam, Jeong Hoon Lee, Sae-Won Han, Do-Youn Oh, Jung Hwan Yoon, Tae-You Kim, Yu Jung Kim, Keun Wook Lee, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Lee, Jee Hyun Kim, Seock-Ah Im
    Breast Cancer.2014; 21(4): 387.     CrossRef
  • Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma
    Seung Up Kim, Kyu Sik Jung, Sarah Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Kwang‐Hyub Han, Young Nyun Park
    Liver International.2014; 34(7): 1008.     CrossRef
  • A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma
    Tae Won Lim, Hee Taek Oh, Seung Un Song, Hae Won Lee, Ji Yeon Kim, Seon Ja Park
    Kosin Medical Journal.2014; 29(2): 161.     CrossRef
  • Long‐term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
    Yoon Hea Park, Beom Kyung Kim, Ja Kyung Kim, Hyeon Chang Kim, Do Young Kim, Jun Yong Park, Kwang‐Hyub Han, Seung Up Kim, Seung Hwan Shin, Kyu Yeon Hahn, Sang Hoon Ahn
    Journal of Gastroenterology and Hepatology.2014; 29(5): 1005.     CrossRef
  • Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B (ACE study): a 2‐year follow‐up randomized controlled trial
    Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Chang Wook Kim, Chang Don Lee, Sang Hoon Park, Myung Seok Lee, Choong Kee Park, Hee Bok Chae, Moon Young Kim, Soon Koo Baik, Yun Soo Kim, Ju Hyun Kim, Jung Il Lee, Jin Woo Lee, Sun Pyo Hong, Soon Ho Um
    Liver International.2013; 33(2): 244.     CrossRef
  • Comparison of chemiluminescence immunoassay (CIA) and immunochromatography assay(ICA) for Detecting HBsAg and Anti-HBs
    Hye-Jeong Kim, Eun-Hee Kim
    Journal of the Korea Academia-Industrial cooperation Society.2013; 14(7): 3419.     CrossRef
  • Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports
    Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park
    BMC Research Notes.2013;[Epub]     CrossRef
  • Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D
    Lucio Boglione, Antonio D'Avolio, Giuseppe Cariti, Gabriella Gregori, Elisa Burdino, Lorena Baietto, Jessica Cusato, Valeria Ghisetti, Francesco G. De Rosa, Giovanni Di Perri
    Liver International.2013; 33(4): 580.     CrossRef
  • Assessment of the Quality of Clinical Practice Guidelines in Korea Using the AGREE Instrument
    Min-Woo Jo, Jin Yong Lee, Nam-Soon Kim, Soo-Young Kim, Seungsoo Sheen, Seon Ha Kim, Sang-il Lee
    Journal of Korean Medical Science.2013; 28(3): 357.     CrossRef
  • Early on‐treatment change in liver stiffness predicts development of liver‐related events in chronic hepatitis B patients receiving antiviral therapy
    Beom K. Kim, Hyun J. Oh, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Kwang H. Han, Yehyun Park, Eun J. Yoo, Young N. Park, Seung U. Kim
    Liver International.2013; 33(2): 180.     CrossRef
  • Trends in the seroprevalence of hepatitis B surface antigen in the South Korean population
    Seung Ha Park
    International Journal of Infectious Diseases.2012; 16(9): e669.     CrossRef
  • Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg‐negative carriers
    Hana Park, Jung Min Lee, Ju Hee Seo, Hyon Suk Kim, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Chae Yoon Chon, Jun Yong Park
    Liver International.2012; 32(5): 796.     CrossRef
  • KASL Clinical Practice Guidelines: Management of chronic hepatitis B

    Clinical and Molecular Hepatology.2012; 18(2): 109.     CrossRef
  • Simple Scoring System Predicting Genotypic Resistance During Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
    Jeong-Hoon Lee, Jung-Hwan Yoon, Eun Ju Cho, Hyo Joon Yang, Eun Sun Jang, Min-Sun Kwak, Sang Youn Hwang, Su Jong Yu, Chang-Hoon Lee, Yoon Jun Kim, Chung Yong Kim, Hyo-Suk Lee
    Journal of Clinical Gastroenterology.2012; 46(3): 243.     CrossRef
  • The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study
    Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik
    Gut and Liver.2012; 6(2): 241.     CrossRef
  • Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
    Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
    Clinical and Molecular Hepatology.2012; 18(2): 195.     CrossRef
  • Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy
    Yeo Myeong Kim, Sook-Hyang Jeong, Jin-Wook Kim, Sang Hyub Lee, Jin Hyuk Hwang, Young Soo Park, Nayoung Kim, Jong Seok Lee, Hyun Young Kim, Dong Ho Lee
    Journal of Clinical Virology.2011; 51(4): 241.     CrossRef
  • Frequently used antiviral agents in the clinical environment
    Seunghoon Han, Dong-Seok Yim
    Journal of the Korean Medical Association.2011; 54(5): 530.     CrossRef
  • Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
    Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park
    The Korean Journal of Hepatology.2011; 17(3): 199.     CrossRef
  • Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection
    J. W. Jang, S. H. Yoo, J. H. Kwon, C. R. You, S. Lee, J. H. Lee, K. W. Chung
    Alimentary Pharmacology & Therapeutics.2011; 34(11-12): 1337.     CrossRef
  • Characterization of antiphospholipid antibodies in chronic hepatitis B infection
    Ji Young Huh, Dae Young Yi, Seong Gyu Hwang, Jin Jung Choi, Myung Seo Kang
    The Korean Journal of Hematology.2011; 46(1): 36.     CrossRef
  • New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B
    Yoo-Kyung Cho, Byung-Cheol Song
    The Korean Journal of Gastroenterology.2011; 57(3): 144.     CrossRef
  • Comparison of Clevudine and Entecavir for Treatment-naive Patients With Chronic Hepatitis B Virus Infection
    Eileen L. Yoon, Hyung Joon Yim, Hyun Jung Lee, Young Sun Lee, Jeong Han Kim, Eun Suk Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun
    Journal of Clinical Gastroenterology.2011; 45(10): 893.     CrossRef
  • Genotypic resistance to entecavir in chronic hepatitis B patients
    Byeong Uk Kim, Ja Chung Goo, Byeong Chul Park, Soo Ok Kim, Sun Pyo Hong, Jee In Jeong, Hee Bok Chae, Seon Mee Park, Sei Jin Youn
    The Korean Journal of Hepatology.2010; 16(2): 147.     CrossRef
  • A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis B
    Su Young Ahn, Soon Young Ko, Yun Mi Jang, Yong Hoon Choi, Byung Kook Kim, Won Hyeok Choe, Chang Hong Lee, So Young Kwon
    The Korean Journal of Gastroenterology.2010; 56(2): 117.     CrossRef
  • Experience with Entecavir Therapy for Lamivudine-Resistant Chronic Hepatitis B in Korean Children and Adolescents
    Seung Man Cho, Byung-Ho Choe, Mi Ae Chu, Jung-Mi Kim
    Korean Journal of Pediatric Gastroenterology and Nutrition.2010; 13(1): 44.     CrossRef
  • Management of Chronic Hepatitis B with Nucleoside or Nucleotide Analogues: A Review of Current Guidelines
    Moon Seok Choi, Byung Chul Yoo
    Gut and Liver.2010; 4(1): 15.     CrossRef
  • Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
    Jae Keun Lee, Ju Hyun Shim, Han Chu Lee, Sae Hwan Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
    Hepatology.2010; 51(5): 1577.     CrossRef
  • Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM
    Neung Hwa Park
    The Korean Journal of Hepatology.2009; 15(1): 106.     CrossRef
  • Clinical efficacy of entecavir therapy and factors associated with treatment response in naïve chronic hepatitis B patients
    Myoung Hee Lee, Sun-Gyo Lim, Su Jin Jeon, Chang Joon Kang, Young Ju Cho, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho
    The Korean Journal of Hepatology.2009; 15(4): 446.     CrossRef
  • Treatment of Hepatitis B Virus Resistant to Lamivudine and Adefovir
    Jin-Wook Kim
    The Korean Journal of Gastroenterology.2009; 53(5): 329.     CrossRef
  • Antiviral Therapy for Chronic Hepatitis B
    Kwan Sik Lee
    Journal of the Korean Medical Association.2009; 52(8): 831.     CrossRef
  • Clevudine therapy in patients with chronic hepatitis B
    Kwan Sik Lee
    The Korean Journal of Hepatology.2009; 15(2): 119.     CrossRef
  • Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone†
    Ju Hyun Shim, Dong Jin Suh, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
    Hepatology.2009; 50(4): 1064.     CrossRef
  • Early development of clevudine resistance during clevudine therapy in a patient with chronic hepatitis B who received prior lamivudine therapy
    Yun Soo Kim, Geum‐Ha Kim, You‐Jin Hwang, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
    Liver International.2009; 29(6): 950.     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

KASL Guidelines : Management of Chronic Hepatitis B
Korean J Hepatol. 2007;13(4):447-488.   Published online December 20, 2007
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
KASL Guidelines : Management of Chronic Hepatitis B
Korean J Hepatol. 2007;13(4):447-488.   Published online December 20, 2007
Close